Michael Fanger is currently Founder, Chairman, and CSO of Celdara Medical, LLC. Previously, Dr. Fanger was co-founder, President and Chief Executive Officer of Celldex Therapeutics Inc. (NASDAQ: CLDX), as well as the co-founder and Director of Medarex, Inc. (previously NASDAQ: MEDX, acquired by BMS in 2009) from its inception in 1987 until 2004. Dr. Fanger has been a Professor of Microbiology and Immunology and Medicine at Dartmouth Medical School since 1981, and was a Chairman of the Department of Microbiology and Immunology from 1992 until 2002. Dr. Fanger is co-inventor on 91 patents covering novel biological therapeutics and software technologies, and co-author on 160 research publications in leading scientific journals. He is a graduate of Wabash College with a BS in Chemistry and received his PhD in Biochemistry from Yale University.